Survival differences between the USA and an urban population from China for all cancer types and 20 individual cancers: a population-based study.

ABSTRACT:

Background

The systematic comparison of cancer survival between China and the USA is rare. Here we aimed to assess the magnitude of survival disparities and disentangle the impact of the stage at diagnosis between a Chinese metropolitan city and the USA on cancer survival.

Methods

We included 11,046 newly diagnosed cancer patients in Dalian Cancer Registry, China, 2015, with the follow-up data for vital status until December 2020. We estimated age-standardised 5-year relative survival and quantified the excess hazard ratio (EHR) of death using generalised linear models for all cancers and 20 individual cancers. We compared these estimates with 17 cancer registries' data from the USA, using the Surveillance, Epidemiology, and End Results database. We further estimated the sta

SUBMITTER: Fu R 

PROVIDER: S-EPMC10485681 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature